Freedom vs Robinhood Markets
FRHC and HOOD side by side, both in security brokers, dealers, and flotation. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FRHC and HOOD compare
Robinhood Markets is the larger company, worth 6.7 times as much as Freedom ($62.3B against $9.3B).
On earnings, Robinhood Markets is cheaper: it trades at 31.9× trailing earnings, against 57.6× for Freedom.
Robinhood Markets grew revenue faster over the last twelve months (20.9% versus 15.3% for Freedom).
Robinhood Markets keeps more of each dollar of sales as profit, with a net margin of 39.0% compared with 6.5% at Freedom.
Robinhood Markets scores higher on the StockData Score (10 against 7 for Freedom), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FRHC | HOOD |
|---|---|---|
| Size and price | ||
| Market cap | $9.3B | $62.3B |
| Share price | $145.82 | $69.19 |
| Change, 1 year | 3.7% | −43.5% |
| Change, 5 years | 116% | 148% |
| Beta (5Y) | 0.30 | 3.23 |
| Employees | 12K | 2,900 |
| StockData Score | ||
| Total score | 7 | 10 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 3 (better) |
| Performance score | 1 | 4 (better) |
| Health score | 4 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 57.6× | 31.9× (better) |
| P/S | 3.9× (better) | 12.3× |
| P/B | 6.1× | – |
| EV/EBITDA | 31.0× | – |
| FCF yield | −9.6% | – |
| Fair value | $77.09 | – |
| Margin of safety | −89.2% | – |
| Growth | ||
| Revenue growth (TTM) | 15.3% | 20.9% (better) |
| Revenue growth, 5Y average | 44.6% (better) | 36.1% |
| Net income growth (TTM) | 95.1% (better) | −9.6% |
| EPS growth (TTM) | 94.6% (better) | −9.6% |
| EPS growth, 5Y average | −0.39% | 190% (better) |
| Profitability | ||
| Gross margin | 95.8% | – |
| Net margin | 6.5% | 39.0% (better) |
| FCF margin | −37.2% | – |
| Return on equity | 11.2% | 23.2% (better) |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Current ratio | – | 1.24 |
| Altman Z-score | 0.74 | 1.07 (better) |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Buyback yield | – | 1.3% |
| Shareholder yield | 0.00% | 1.3% (better) |
| Ownership | ||
| Held by institutions | 3.5% | 68.3% |
| Held by insiders | 68.1% | 13.8% |
| Insider net buying, 12 months | −$8.7M (better) | −$276M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 5.1% | 4.5% |
Go deeper
- FRHC stock overview
- FRHC income statement
- FRHC valuation and score
- HOOD stock overview
- HOOD income statement
- HOOD valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.